Cognitive impairment in COPD: Should cognitive evaluation be part of respiratory assessment?

Breathe

Volumn 13, Issue 1, 2017, Pages e1-e9

  Andrianopoulos, Vasileios ^a   Gloeckl, Rainer ^a,b   Vogiatzis, Ioannis ^c,d   Kenn, Klaus ^a,e  

^a Dept of Respiratory Medicine and Pulmonary Rehabilitation   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF ATHENS   (Greece)

^d NORTHUMBRIA UNIVERSITY   (United Kingdom)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADDENBROOKE COGNITIVE EXAMINATION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CLOCK DRAWING TEST; COGNITION ASSESSMENT; COGNITIVE DEFECT; FUNCTIONAL DISEASE; HUMAN; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROPSYCHOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PULMONARY REHABILITATION; RESPIRATORY TRACT EXAMINATION; RISK ASSESSMENT; RISK FACTOR; TREATMENT PLANNING;

EID: 85032259257     PISSN: 18106838     EISSN: 20734735     Source Type: Journal    
DOI: 10.1183/20734735.001417     Document Type: Article

References (84)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. 2017 http://goldcopd.org/gold-2017-globalstrategy- diagnosis-management-prevention-copd/ Date last accessed: March 14 2017.
2. Hung WW, Wisnivesky JP, Siu AL, et al. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180: 134-137.
3. Ortapamuk H, Naldoken S. Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment. Ann Nucl Med 2006; 20: 99-106.
4. Campbell NL, Boustani MA, Skopelja EN, et al. Medication adherence in older adults with cognitive impairment: a systematic evidence-based review. Am J Geriatr Pharmacother 2012; 10: 165-177.
5. Perneczky R, Pohl C, Sorg C, et al. Impairment of activities of daily living requiring memory or complex reasoning as part of the MCI syndrome. Int J Geriatr Psychiatry 2006; 21: 158-162.
6. Chang SS, Chen S, McAvay GJ, et al. Effect of coexisting chronic obstructive pulmonary disease and cognitive impairment on health outcomes in older adults. J Am Geriatr Soc 2012; 60:1839-1846.
7. Dodd JW. Lung disease as a determinant of cognitive decline and dementia. Alzheimers Res Ther 2015; 7: 32.
8. Torres-Sanchez I, Rodriguez-Alzueta E, Cabrera-Martos I, et al.Cognitive impairment in COPD: a systematic review. J Bras Pneumol 2015; 41: 182-190.
9. Dodd JW, Charlton RA, van den Broek MD, et al. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest 2013; 144: 119-127.
10. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J 2010; 35: 913-922.
11. Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349: 1793-1796.
12. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58:1985-1992.
13. Villeneuve S, Pepin V, Rahayel S, et al. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest 2012; 142: 1516-1523.
14. Vanfleteren LE. Does COPD stand for “COmorbidity with Pulmonary Disease”? Eur Respir J 2015; 45: 14-17.
15. Cleutjens FA, Wouters EF, Dijkstra JB, et al. The COgnitive-Pulmonary Disease (COgnitive-PD) study:protocol of a longitudinal observational comparative study on neuropsychological functioning of patients with COPD. BMJ Open 2014; 4: e004495.
16. Farrell D. Examples and principles of psychology in the bible. Enumclaw, WA, USA, Redemption Press, 2010.
17. Oxford Living Dictionaries. Definition of cognition in English. Oxford, Oxford University Press, 2017. https://en.oxforddictionaries. com/definition/cognition Date last accessed: March 14 2017.
18. Cleutjens FA, Janssen DJ, Ponds RW, et al. COgnitivepulmonary disease. Biomed Res Int 2014; 2014: 697825.
19. Sachdev PS, Blacker D, Blazer DG, et al. Classifying neurocognitive disorders: the DSM-5 approach. Nat Rev Neurol 2014; 10: 634-642.
20. Cullen B, O’Neill B, Evans JJ, et al. A review of screening tests for cognitive impairment. J Neurol Neurosurg Psychiatr 2007; 78: 790-799.
21. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-194.
22. Lonie JA, Tierney KM, Ebmeier KP. Screening for mild cognitive impairment: a systematic review. Int J Geriatr Psychiatry 2009; 24: 902-915.
23. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
24. Mathuranath PS, Nestor PJ, Berrios GE, et al. A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology 2000; 55: 1613-1620.
25. Mioshi E, Dawson K, Mitchell J, et al. The Addenbrooke’s Cognitive’ Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006; 21: 1078-1085.
26. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53:695-699.
27. Agrell B, Dehlin O. The clock-drawing test. Age Ageing 1998; 27: 399-403.
28. Borson S, Scanlan J, Brush M, et al. The mini-cog: a cognitive ‘vital signs’ measure for dementia screening in multilingual elderly. Int J Geriatr Psychiatry 2000; 15: 1021-1027.
29. Brandt J, Spencer M, Folstein M. Telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1988; 1: 111-118.
30. Gatz M, Reynolds CA, John R, et al. Telephone screening to identify potential dementia cases in a population-based sample of older adults. Int Psychogeriatr 2002; 14: 273-289.
31. Tsoi KK, Chan JY, Hirai HW, et al. Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Inter Med 2015; 175: 1450-1458.
32. Crews WD, Jefferson AL, Bolduc T, et al.Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease. Arch Clin Neuropsychol 2001; 16: 643-652.
33. Antonelli-Incalzi R, Corsonello A, Trojano L, et al.Screening of cognitive impairment in chronic obstructive pulmonary disease. Dement Geriatr Cogn Disord 2007; 23:264-270.
34. Andreou G, Vlachos F, Makanikas K. Effects of chronic obstructive pulmonary disease and obstructive sleep apnea on cognitive functions: evidence for a common nature. Sleep Disord 2014; 2014: 768210.
35. Hall JE. Guyton and Hall Textbook of Medical Physiology. 12th Edn. Philadelphia, Saunders Elsevier, 2011; pp. 743-750.
36. Lee JM, Grabb MC, Zipfel GJ, et al. Brain tissue responses to ischemia. J Clin Invest 2000; 106: 723-731.
37. Thakur N, Blanc PD, Julian LJ, et al. COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. Int J Chron Obstruct Pulmon Dis 2010; 5: 263-269.
38. Incalzi RA, Gemma A, Marra C, et al. Chronic obstructive pulmonary disease. An original model of cognitive decline. Am Rev Respir Dis 1993; 148: 418-424.
39. Incalzi RA, Gemma A, Marra C, et al. Verbal memory impairment in COPD: its mechanisms and clinical relevance. Chest 1997; 112: 1506-1513.
40. Klein M, Gauggel S, Sachs G, et al. Impact of chronic obstructive pulmonary disease (COPD) on attention functions. Respir Med 2010; 104: 52-60.
41. Zheng GQ, Wang Y, Wang XT. Chronic hypoxiahypercapnia influences cognitive function: a possible new model of cognitive dysfunction in chronic obstructive pulmonary disease. Med Hypotheses 2008; 71: 111-113.
42. Liesker JJ, Postma DS, Beukema RJ, et al. Cognitive performance in patients with COPD. Respir Med 2004; 98:351-356.
43. Van de Ven MJ, Colier WN, Van der Sluijs MC, et al.Ventilatory and cerebrovascular responses in normocapnic and hypercapnic COPD patients. Eur Respir J 2001; 18: 61-68.
44. Sartori AC, Vance DE, Slater LZ, et al. The impact of inflammation on cognitive function in older adults:implications for healthcare practice and research. J Neurosci Nurs 2012; 44: 206-217.
45. Baierle M, Nascimento SN, Moro AM, et al. Relationship between inflammation and oxidative stress and cognitive decline in the institutionalized elderly. Oxid Med Cell Longev 2015; 2015: 804198.
46. Plassman BL, Williams JW Jr, Burke JR, et al. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med 2010; 153:182-193.
47. Foglio K, Carone M, Pagani M, et al. Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction. Respir Med 2000; 94: 256-263.
48. Lee AY. Vascular dementia. Chonnam Med J 2011; 47:66-71.
49. Reitz C, Tang MX, Manly J, et al. Hypertension and the risk of mild cognitive impairment. Arch Neurol 2007; 64:1734-1740.
50. Duschek S, Meinhardt J, Schandry R. Reduced cortical activity due to chronic low blood pressure: an EEG study. Biol Psychol 2006; 72: 241-250.
51. Zur D, Naftaliev E, Kesler A. Evidence of multidomain mild cognitive impairment in idiopathic intracranial hypertension. J Neuroophthalmol 2015; 35: 26-30.
52. Ambrosino N, Bruletti G, Scala V, et al. Cognitive and perceived health status in patient with chronic obstructive pulmonary disease surviving acute on chronic respiratory failure: a controlled study. Intensive Care Med 2002; 28:170-177.
53. Mansvelder HD, van Aerde KI, Couey JJ, et al. Nicotinic modulation of neuronal networks: from receptors to cognition. Psychopharmacology (Berl) 2006; 184: 292-305.
54. Wollam ME, Weinstein AM, Saxton JA, et al. Genetic risk score predicts late-life cognitive impairment. J Aging Res 2015; 2015: 267062.
55. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to ageassociated diseases. J Gerontol A Biol Sci Med Sci 2014; 69, Suppl. 1: S4-S9.
56. Strandgaard S, Paulson OB. Cerebrovascular consequences of hypertension. Lancet 1994; 344: 519-521.
57. Duschek S, Matthias E, Schandry R. Essential hypotension is accompanied by deficits in attention and working memory. Behav Med 2005; 30: 149-158.
58. Andreassi JL. Psychophysiology: human behavior and physiological response. Int J Psychophysiol 2007; 65: 174-175.
59. Hamel R, Ramakers I, Oosterveld S, et al. The influence of comorbidities on cognitive decline and conversion to dementia with mild cognitive impairment. Alzheimers & Dementia 2014; 10: P139.
60. Flint J. Genetic basis of cognitive disability. Dialogues Clin Neurosci 2001; 3: 37-46.
61. Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment: ten years later. Arch Neurol 2009; 66:1447-1455.
62. Carvalhaes-Neto N, Lorino H, Gallinari C, et al.Cognitive function and assessment of lung function in the elderly. Am J Respir Crit Care Med 1995; 152, Issue 5_pt_1:1611-1615.
63. Tang A, Eng JJ, Tsang TS, et al. Cognition and motor impairment correlates with exercise test performance after stroke. Med Sci Sports Exerc 2013; 45: 622-627.
64. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008; 63: 831-838.
65. Restrepo RD, Alvarez MT, Wittnebel LD, et al.Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 2008; 3: 371-384.
66. Appelbaum PS, Roth LH. Patients who refuse treatment in medical hospitals. JAMA 1983; 250: 1296-1301.
67. Coutts JA, Gibson NA, Paton JY. Measuring compliance with inhaled medication in asthma. Arch Dis Child 1992; 67:332-333.
68. Yu F, Evans LK, Sullivan-Marx EM. Functional outcomes for older adults with cognitive impairment in a comprehensive outpatient rehabilitation facility. J Am Geriatr Soc 2005; 53:1599-1606.
69. Tabert MH, Albert SM, Borukhova-Milov L, et al.Functional deficits in patients with mild cognitive impairment:prediction of AD. Neurology 2002; 58: 758-764.
70. Woodford HJ, George J. Cognitive assessment in the elderly: a review of clinical methods. QJM 2007; 100: 469-484.
71. Hamer M, Chida Y. Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychol Med 2009; 39: 3-11.
72. Blondell SJ, Hammersley-Mather R, Veerman JL. Does physical activity prevent cognitive decline and dementia? A systematic review and meta-analysis of longitudinal studies. BMC Public Health 2014; 14: 510.
73. Agrawal R, Gomez-Pinilla F. ‘Metabolic syndrome’ in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition. J Physiol 2012; 590: 2485-2499.
74. Martin M, Clare L, Altgassen AM, et al. Cognitionbased interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev 2011; CD006220.
75. Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol 2004; 3: 343-353.
76. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: e13-e64.
77. Gomez-Pinilla F, Hillman C. The influence of exercise on cognitive abilities. Compr Physiol 2013; 3: 403-428.
78. Hill K, Vogiatzis I, Burtin C. The importance of components of pulmonary rehabilitation, other than exercise training, in COPD. Eur Respir Rev 2013; 22: 405-413.
79. Tselebis A, Bratis D, Pachi A, et al. A pulmonary rehabilitation program reduces levels of anxiety and depression in COPD patients. Multidiscip Respir Med 2013; 8: 41.
80. Spielmanns M, Gloeckl R, Schmoor C, et al. Effects on pulmonary rehabilitation in patients with COPD or ILD: a retrospective analysis of clinical and functional predictors with particular emphasis on gender. Respir Med 2016; 113: 8-14.
81. Kenn K, Gloeckl R, Soennichsen A, et al. Predictors of success for pulmonary rehabilitation in patients awaiting lung transplantation. Transplantation 2015; 99: 1072-1077.
82. Pereira ED, Viana CS, Taunay TC, et al. Improvement of cognitive function after a three-month pulmonary rehabilitation program for COPD patients. Lung 2011; 189: 279-285.
83. Kozora E, Tran ZV, Make B. Neurobehavioral improvement after brief rehabilitation in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2002; 22:426-430.
84. Karamanli H, Ilik F, Kayhan F, et al. Assessment of cognitive impairment in long-term oxygen therapy-dependent COPD patients. Int J Chron Obstruct Pulmon Dis 2015; 10:2087-2094.